The Medicare GLP-1 Bridge Program: How Seniors Can Access $50 Weight-Loss Meds

Starting July 1, 2026, the federal government is launching the temporary Medicare GLP-1 Bridge Program. Breaking a decades-old ban, this pilot program allows eligible Medicare Part D beneficiaries to access blockbusters like Wegovy®, the Zepbound® KwikPen®, and Foundayo® for a flat $50 monthly copay. We outline the strict BMI tiers, required prior authorization steps, and hidden catches you must know.